{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:24:40Z","timestamp":1790630680071,"version":"4.1.0"},"reference-count":34,"publisher":"Impact Journals, LLC","issue":"32","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,8,8]]},"DOI":"10.18632\/oncotarget.18411","type":"journal-article","created":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T16:05:37Z","timestamp":1496937937000},"page":"53366-53374","source":"Crossref","is-referenced-by-count":27,"title":["Dectin-1 signaling inhibits osteoclastogenesis via IL-33-induced inhibition of NFATc1"],"prefix":"10.18632","volume":"8","author":[{"given":"Xiaoqing","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Hematology, The First Hospital of Jilin University, Changchun 130061, China"},{"name":"Department of Hematology, Ningbo Hangzhou Bay Hospital, Ningbo 315336, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghua","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cancer Immunology, Institute of Translational Medicine, The First Hospital of Jilin University, Changchun 130061, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxue","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Cancer Immunology, Institute of Translational Medicine, The First Hospital of Jilin University, Changchun 130061, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxue","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Hospital of Jilin University, Changchun 130061, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cancer Immunology, Institute of Translational Medicine, The First Hospital of Jilin University, Changchun 130061, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Cancer Immunology, Institute of Translational Medicine, The First Hospital of Jilin University, Changchun 130061, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Cancer Immunology, Institute of Translational Medicine, The First Hospital of Jilin University, Changchun 130061, China"},{"name":"Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujun","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Hospital of Jilin University, Changchun 130061, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cancer Immunology, Institute of Translational Medicine, The First Hospital of Jilin University, Changchun 130061, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,6,8]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00774-008-0011-0","article-title":"Comparison of osteoclast precursors in peripheral blood mononuclear cells from rheumatoid arthritis and osteoporosis patients","volume":"27","author":"Teshima","year":"2009","journal-title":"J Bone Miner Metab"},{"key":"2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1517\/14728220903525720","article-title":"Dickkopf-1 as a potential therapeutic target in Paget\u2019s disease of bone","volume":"14","author":"Marshall","year":"2010","journal-title":"Expert Opin Ther Targets"},{"key":"3","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1158\/1078-0432.CCR-10-1804","article-title":"Advances in the biology and treatment of bone disease in multiple myeloma","volume":"17","author":"Roodman","year":"2011","journal-title":"Clin Cancer Res"},{"key":"4","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1634\/theoncologist.2009-0003","article-title":"Myeloma bone disease: recent advances in biology, diagnosis, and treatment","volume":"14","author":"Sezer","year":"2009","journal-title":"Oncologist"},{"key":"5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/leu.2011.282","article-title":"Bisphosphonates as antimyeloma drugs","volume":"26","author":"Lentzsch","year":"2012","journal-title":"Leukemia"},{"key":"6","doi-asserted-by":"crossref","first-page":"JC34","DOI":"10.7326\/ACPJC-2017-166-6-034","article-title":"Review: different bisphosphonates are equally effective and safe for preventing fragility fractures","volume":"166","author":"Htay","year":"2017","journal-title":"Ann Intern Med"},{"key":"7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12891-017-1514-4","article-title":"Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis","volume":"18","author":"Lee","year":"2017","journal-title":"BMC Musculoskelet Disord"},{"key":"8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.coph.2016.02.013","article-title":"New approaches to targeting the bone marrow microenvironment in multiple myeloma","volume":"28","author":"Edwards","year":"2016","journal-title":"Curr Opin Pharmacol"},{"key":"9","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/leu.2008.336","article-title":"Pathogenesis of myeloma bone disease","volume":"23","author":"Roodman","year":"2009","journal-title":"Leukemia"},{"key":"10","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa030847","article-title":"The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma","volume":"349","author":"Shaughnessy","year":"2003","journal-title":"N Engl J Med"},{"key":"11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bbrc.2016.05.019","article-title":"Osteoclast function and bone-resorbing activity: an overview","volume":"476","author":"Alles","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.5312\/wjo.v3.i11.167","article-title":"Molecular mechanisms of triggering, amplifying and targeting RANK signaling in osteoclasts","volume":"3","author":"Matsuo","year":"2012","journal-title":"World J Orthop"},{"key":"13","first-page":"48","article-title":"Classical and paradoxical effects of TNF-alpha on bone homeostasis","volume":"5","author":"Miossec","year":"2014","journal-title":"Front Immunol"},{"key":"14","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.4049\/jimmunol.169.7.3876","article-title":"The beta-glucan receptor, dectin-1, is predominantly expressed on the surface of cells of the monocyte\/macrophage and neutrophil lineages","volume":"169","author":"Wong","year":"2002","journal-title":"J Immunol"},{"key":"15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nri1745","article-title":"Dectin-1: a signalling non-TLR pattern-recognition receptor","volume":"6","author":"Brown","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/35092620","article-title":"Immune recognition. A new receptor for beta-glucans","volume":"413","author":"Gordon","year":"2001","journal-title":"Nature"},{"key":"17","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.imbio.2008.11.003","article-title":"C-type lectins and phagocytosis","volume":"214","author":"Brown","year":"2009","journal-title":"Immunobiology"},{"key":"18","doi-asserted-by":"crossref","first-page":"19191","DOI":"10.1074\/jbc.M114.551416","article-title":"The dectin 1 agonist curdlan regulates osteoclastogenesis by inhibiting nuclear factor of activated T cells cytoplasmic 1 (NFATc1) through Syk kinase","volume":"289","author":"Nishihara","year":"2014","journal-title":"J Biol Chem"},{"key":"19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.intimp.2016.01.020","article-title":"Biaryl amide compounds reduce the inflammatory response in macrophages by regulating Dectin-1","volume":"32","author":"Hwang","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"20","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.molimm.2015.09.013","article-title":"Sonic hedgehog-responsive lipoxygenases and cyclooxygenase-2 modulate Dectin-1-induced inflammatory cytokines","volume":"68","author":"Balaji","year":"2015","journal-title":"Mol Immunol"},{"key":"21","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.4049\/jimmunol.1502044","article-title":"RBP-J-regulated miR-182 promotes TNF-alpha-induced osteoclastogenesis","volume":"196","author":"Zhao","year":"2016","journal-title":"J Immunol"},{"key":"22","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jbspin.2014.04.012","article-title":"Increased RANKL-mediated osteoclastogenesis by interleukin-1beta and endoplasmic reticulum stress","volume":"81","author":"Yoo","year":"2014","journal-title":"Joint Bone Spine"},{"key":"23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/978-3-319-40320-5_14","article-title":"Bone disease in multiple myeloma","volume":"169","author":"Raje","year":"2016","journal-title":"Cancer Treat Res"},{"key":"24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.micpath.2003.12.003","article-title":"Bone marrow colony-formationafter infection of genetically defined inbred mice with Candida albicans","volume":"36","author":"Ashman","year":"2004","journal-title":"Microb Pathog"},{"key":"25","doi-asserted-by":"crossref","first-page":"e0131041","DOI":"10.1371\/journal.pone.0131041","article-title":"CXCL8 and CCL20 enhance osteoclastogenesis via modulation of cytokine production by human primary osteoblasts","volume":"10","author":"Bravenboer","year":"2015","journal-title":"PLoS One"},{"key":"26","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s12026-014-8528-x","article-title":"Preclinical validation of interleukin 6 as a therapeutic target in multiple myeloma","volume":"59","author":"Janz","year":"2014","journal-title":"Immunol Res"},{"key":"27","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/en.2010-1268","article-title":"Interleukin-33, a target of parathyroid hormone and oncostatin M, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro","volume":"152","author":"Quinn","year":"2011","journal-title":"Endocrinology"},{"key":"28","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/jbmr.269","article-title":"Interleukin-33 is expressed in differentiated osteoblasts and blocks osteoclast formation from bone marrow precursor cells","volume":"26","author":"Schett","year":"2011","journal-title":"J Bone Miner Res"},{"key":"29","doi-asserted-by":"crossref","first-page":"15502","DOI":"10.1073\/pnas.1410700111","article-title":"Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells","volume":"111","author":"Girard","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.immuni.2009.05.007","article-title":"Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases","volume":"31","author":"Martin","year":"2009","journal-title":"Immunity"},{"key":"31","first-page":"423957","article-title":"Interleukin-33 and inflammatory bowel diseases: lessons from human studies","volume":"2014","author":"de Souza","year":"2014","journal-title":"Mediators Inflamm"},{"key":"32","doi-asserted-by":"crossref","first-page":"7890","DOI":"10.4049\/jimmunol.0802449","article-title":"Caspase-1, caspase-8, and calpain are dispensable for IL-33 release by macrophages","volume":"183","author":"Nakae","year":"2009","journal-title":"J Immunol"},{"key":"33","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S8756-3282(01)00654-8","article-title":"The generation of highly enriched osteoclast-lineage cell populations","volume":"30","author":"Hamilton","year":"2002","journal-title":"Bone"},{"key":"34","doi-asserted-by":"crossref","first-page":"12368","DOI":"10.1038\/ncomms12368","article-title":"Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells","volume":"7","author":"Lu","year":"2016","journal-title":"Nat Commun"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.18411","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T21:27:25Z","timestamp":1589146045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.18411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,8]]},"references-count":34,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2017,8,8]]}},"alternative-id":["18411","28881817"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.18411","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,8]]}}}